Interferon Beta-1A | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Interferon Beta-1A
HEALTH CANADA PATENTS

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Interferon Beta-1A

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 2 Listed Suppliers

2 API Suppliers
2 Listed Suppliers

DEVELOPMENTS

26 Drugs in Development

26 Drugs in Development

FINISHED DOSAGE FORMULATIONS

66 FDF Dossiers, 3 FDA Orange Book, 47 Europe, 5 Canada, 8 South Africa, 3 Listed Dossiers

66 FDF Dossiers
3 FDA Orange Book
47 Europe
5 Canada
8 South Africa
3 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 12 SPI Pharma, 1 Faran Shimi Pharmaceutical, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 2 Actylis, 2 BASF, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 3 Kerry, 2 Microlex e.U, 2 Pluviaendo, 3 Roquette, 2 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

1 Rochem International Inc
12 SPI Pharma
1 Faran Shimi Pharmaceutical
1 Nanjing Well Pharmaceutical
1 Pfanstiehl
2 Actylis
2 BASF
2 Gangwal Chemicals
1 Ingredion Pharma Solutions
3 Kerry
2 Microlex e.U
2 Pluviaendo
3 Roquette
2 Seppic
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 10 Chewable & Orodispersible Aids, 9 Parenteral, 9 Taste Masking, 9 Direct Compression, 4 Solubilizers, 4 Co-Processed Excipients, 3 Disintegrants & Superdisintegrants, 3 Granulation, 3 Topical, 2 Surfactant & Foaming Agents, 2 Thickeners and Stabilizers, 1 API Stability Enhancers, 1 Film Formers & Plasticizers, 1 Controlled & Modified Release, 1 Emulsifying Agents, 1 Coating Systems & Additives

17 Fillers, Diluents & Binders
10 Chewable & Orodispersible Aids
9 Parenteral
9 Taste Masking
9 Direct Compression
4 Solubilizers
4 Co-Processed Excipients
3 Disintegrants & Superdisintegrants
3 Granulation
3 Topical
2 Surfactant & Foaming Agents
2 Thickeners and Stabilizers
1 API Stability Enhancers
1 Film Formers & Plasticizers
1 Controlled & Modified Release
1 Emulsifying Agents
1 Coating Systems & Additives

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 31 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
31 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 34 Finished Drug Prices, 13 Annual Reports

2 US Medicaid Prescriptions
34 Finished Drug Prices
13 Annual Reports

MARKET PLACE

1 APIs, 4 FDF Dossiers

1 APIs
4 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 Health Canada Patents

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 Others

1 EDQM
1 Others

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 1Gowling Lafleur Henderson LLP

02 2Gowling WLG (Canada) LLP

filter Patent Reset all filters

3 All

01 21341604

02 12275890

filter Product Reset all filters

3 All

01 3Interferon beta-1a

filter Dosage Reset all filters

3 All

01 1Lyophilized powder for resonstitution

02 2solution

filter Exp Date Reset all filters

3 All

01 12017-12-23

02 22027-05-04

Product Main Page

01

Gowling WLG (Canada) LLP

Interferon Beta-1A

Pharma, Lab & Chemical Expo

Not Confirmed

Gowling WLG (Canada) LLP

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-05-04

Date Granted : 2010-05-04

Interferon Beta-1A

Brand Name : AVONEX

Patent Number : 1341604

Filing Date : 1981-04-04

Strength per Unit : 30 mcg / 0.5mL

Dosage Form : solution

Human Or VET : Human

Route of Administration : Intramuscular

Patent Expiration Date : 2027-05-04

Date Granted : 2010-05-04

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling WLG (Canada) LLP

Interferon Beta-1A

Pharma, Lab & Chemical Expo

Not Confirmed

Gowling WLG (Canada) LLP

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-05-04

Date Granted : 2010-05-04

Interferon Beta-1A

Brand Name : AVONEX

Patent Number : 1341604

Filing Date : 1981-04-04

Strength per Unit : 30 mcg / mL

Dosage Form : Lyophilized powder for resonstitution

Human Or VET : Human

Route of Administration : Intramuscular injection

Patent Expiration Date : 2027-05-04

Date Granted : 2010-05-04

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling Lafleur Henderson LLP

Interferon Beta-1A

Pharma, Lab & Chemical Expo

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-12-23

Date Granted : 2011-11-01

Interferon Beta-1A

Brand Name : AVONEX

Patent Number : 2275890

Filing Date : 1997-12-23

Strength per Unit : 30 mcg / 0.5mL

Dosage Form : solution

Human Or VET : Human

Route of Administration : Intramuscular

Patent Expiration Date : 2017-12-23

Date Granted : 2011-11-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?